Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Mar-24 5:51 PM View:  | Fogarty Krista Principal Accounting Officer | Lipocine Inc. (LPCN) | 08-Mar-24 | Grant | 991 | -- | -- | 135% 0.74K to 1.73K | |
| 12-Mar-24 5:53 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 08-Mar-24 | Grant | 4,893 | -- | -- | 5% 107.42K to 112.31K | |
| 25-May-23 3:10 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 25-May-23 | Purchase | 8,706 | $5.03 | $43,791.20 | 9% 98.71K to 107.42K | |
| 24-Mar-23 5:28 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 24-Mar-23 | Private Purchase | 150,000 | $0.32 | $48,000.00 | 10% 1.53M to 1.68M | |
| 20-Mar-23 6:51 PM View: | Ono Richard Dana Director | Lipocine Inc. (LPCN) | 20-Mar-23 | Private Purchase | 4,000 | $0.34 | $1,360.00 | 40% 10.13K to 14.13K | |
| 17-Mar-23 4:31 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 17-Mar-23 | Private Purchase | 50,000 | $0.33 | $16,500.00 | 3% 1.48M to 1.53M | |
| 28-Nov-22 4:33 PM View: | Papapetropoulos Spyridon Director | Lipocine Inc. (LPCN) | 22-Nov-22 | Private Purchase | 21,739 | $0.47 | $10,217.30 | 100% 0 to 21.74K | |
| 14-Nov-22 3:58 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 14-Nov-22 | Private Purchase | 75,000 | $0.39 | $29,250.00 | 5% 1.4M to 1.48M | |
| 27-Sep-22 6:53 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 27-Sep-22 | Private Purchase | 100,000 | $0.41 | $41,000.00 | 8% 1.3M to 1.4M | |
| 17-May-22 4:58 PM View: | Fogarty Krista Principal Accounting Officer | Lipocine Inc. (LPCN) | 17-May-22 | Private Purchase | 12,500 | $0.86 | $10,750.00 | 100% 0 to 12.5K | |
| 16-May-22 6:44 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 16-May-22 | Private Purchase | 50,000 | $0.77 | $38,495.00 | 4% 1.25M to 1.3M | |
| 18-Nov-21 7:23 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 18-Nov-21 | Market Purchase | 25,000 | $1.09 | $27,250.00 | 2% 1.23M to 1.25M | 6% |
| 04-Jan-21 2:09 PM View: | Higuchi John W. Director | Lipocine Inc. (LPCN) | 31-Dec-20 | Market Sale | 6,700 | $1.35 | $9,053.50 | (< 1%) 700.25K to 693.55K | (< 1%) |
| 17-Dec-20 4:06 PM View: | Hill Stephen A Director | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 7,500 | -- | -- | 143% 5.25K to 12.75K | |
| 17-Dec-20 4:05 PM View: | Brown Morgan R EVP and CFO | Lipocine Inc. (LPCN) | 16-Dec-20 | Market Option Sale (Planned) | 8,437 | $1.35 | $11,390.00 | (4%) 202.94K to 194.5K | |
| 17-Dec-20 4:07 PM View: | Higuchi John W. Director | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 3,750 | -- | -- | < 1% 696.5K to 700.25K | |
| 17-Dec-20 4:07 PM View: | Fink Jeffrey Arvin Director | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 5,625 | -- | -- | 600% 0.94K to 6.56K | |
| 17-Dec-20 4:07 PM View: | Ono Richard Dana Director | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 5,250 | -- | -- | 108% 4.88K to 10.13K | |
| 17-Dec-20 4:06 PM View: | Patel Mahesh V. Chief Executive Officer Director | Lipocine Inc. (LPCN) | 16-Dec-20 | Market Option Sale (Planned) | 15,000 | $1.35 | $20,250.00 | (1%) 1.24M to 1.23M | |
| 17-Dec-20 4:06 PM View: | Patel Mahesh V. Chief Executive Officer Director | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 45,000 | -- | -- | 4% 1.2M to 1.24M | |
| 17-Dec-20 4:05 PM View: | Brown Morgan R EVP and CFO | Lipocine Inc. (LPCN) | 16-Dec-20 | Option Exercise | 28,125 | -- | -- | 16% 174.82K to 202.94K | |
| 08-Dec-20 4:50 PM View: | Brown Morgan R Chief Financial Officer | Lipocine Inc. (LPCN) | 05-Dec-20 | Option Exercise | 70,754 | -- | -- | 68% 104.06K to 174.82K | |
| 08-Dec-20 4:50 PM View: | Patel Mahesh V. Chief Executive Officer Director | Lipocine Inc. (LPCN) | 05-Dec-20 | Option Exercise | 122,978 | -- | -- | 11% 1.08M to 1.2M | |
| 08-Dec-20 4:50 PM View: | Brown Morgan R Chief Financial Officer | Lipocine Inc. (LPCN) | 04-Dec-20 | Market Option Sale (Planned) | 17,250 | $1.57 | $27,023.80 | (14%) 121.31K to 104.06K | |
| 08-Dec-20 4:50 PM View: | Brown Morgan R Chief Financial Officer | Lipocine Inc. (LPCN) | 04-Dec-20 | Option Exercise | 57,500 | -- | -- | 90% 63.81K to 121.31K | |
| 08-Dec-20 4:50 PM View: | Patel Mahesh V. Chief Executive Officer Director | Lipocine Inc. (LPCN) | 04-Dec-20 | Option Exercise | 145,000 | -- | -- | 15% 973.61K to 1.12M | |
| 08-Dec-20 4:50 PM View: | Patel Mahesh V. Chief Executive Officer Director | Lipocine Inc. (LPCN) | 04-Dec-20 | Market Option Sale (Planned) | 43,500 | $1.57 | $68,134.10 | (4%) 1.12M to 1.08M | |
| 18-Mar-20 11:20 AM View: | Higuchi John W. Director | Lipocine Inc. (LPCN) | 17-Mar-20 | Market Purchase | 220,000 | $0.32 | $69,542.00 | 46% 476.5K to 696.5K | |
| 02-Jan-20 11:22 AM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 31-Dec-19 | Market Purchase | 40,000 | $0.38 | $15,340.00 | 4% 933.61K to 973.61K | 2% |
| 10-Dec-19 1:00 PM View: | Patel Mahesh V. President and CEO Director | Lipocine Inc. (LPCN) | 10-Dec-19 | Market Purchase | 25,000 | $0.40 | $9,975.00 | 3% 908.61K to 933.61K | (2%) |
| 06-Dec-19 10:42 AM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 04-Dec-19 | Market Option Sale (Planned) | 43,500 | $0.41 | $17,835.00 | (5%) 952.11K to 908.61K | |
| 06-Dec-19 10:42 AM View: | Brown Morgan R EVP and Chief Financial Office | Lipocine Inc. (LPCN) | 04-Dec-19 | Option Exercise | 57,500 | -- | -- | 244% 23.56K to 81.06K | |
| 06-Dec-19 10:42 AM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 04-Dec-19 | Option Exercise | 145,000 | -- | -- | 18% 807.11K to 952.11K | |
| 06-Dec-19 10:42 AM View: | Brown Morgan R EVP and Chief Financial Office | Lipocine Inc. (LPCN) | 04-Dec-19 | Market Option Sale (Planned) | 17,250 | $0.41 | $7,075.95 | (21%) 81.06K to 63.81K | |
| 26-Nov-19 11:14 AM View: | Patel Mahesh V. President and CEO Director | Lipocine Inc. (LPCN) | 26-Nov-19 | Market Purchase | 25,000 | $0.43 | $10,696.00 | 3% 782.11K to 807.11K | |
| 18-Nov-19 4:18 PM View: | Patel Mahesh V. CEO and President Director | Lipocine Inc. (LPCN) | 18-Nov-19 | Market Purchase | 50,000 | $0.40 | $20,094.70 | 7% 732.11K to 782.11K | |
| 28-May-19 10:54 AM View: | Patel Mahesh V. President and CEO Director | Lipocine Inc. (LPCN) | 24-May-19 | Grant | 10,000 | $1.60 | $15,984.50 | 1% 722.11K to 732.11K | (2%) |
| 02-Jan-18 6:15 PM View: | Brown Morgan R EVP and CFO | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 2,813 | $3.47 | $9,773.49 | (11%) 26.38K to 23.56K | 51% |
| 02-Jan-18 6:16 PM View: | Bass Gregory Brooks Chief Commercial Officer | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 9,375 | -- | -- | 100% 0 to 9.38K | |
| 02-Jan-18 6:16 PM View: | Patel Mahesh V. CEO, President Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 15,000 | -- | -- | 2% 713.11K to 728.11K | |
| 02-Jan-18 6:16 PM View: | Bass Gregory Brooks Chief Commercial Officer | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 3,750 | $3.47 | $13,023.40 | (40%) 9.38K to 5.63K | 51% |
| 02-Jan-18 6:14 PM View: | Fink Jeffrey Arvin Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 938 | $3.47 | $3,258.33 | (50%) 1.88K to 0.94K | 51% |
| 02-Jan-18 6:15 PM View: | Hill Stephen A Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 2,500 | -- | -- | 62% 4.0K to 6.5K | |
| 02-Jan-18 6:15 PM View: | Hill Stephen A Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 1,250 | $3.47 | $4,341.50 | (19%) 6.5K to 5.25K | 51% |
| 02-Jan-18 6:15 PM View: | Brown Morgan R EVP and CFO | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 9,375 | -- | -- | 55% 17.0K to 26.38K | |
| 02-Jan-18 6:16 PM View: | Patel Mahesh V. CEO, President Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 6,000 | $3.48 | $20,866.80 | (< 1%) 728.11K to 722.11K | 51% |
| 02-Jan-18 6:15 PM View: | Higuchi John W. Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 1,250 | -- | -- | < 1% 475.25K to 476.5K | |
| 02-Jan-18 6:14 PM View: | Fink Jeffrey Arvin Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 1,875 | -- | -- | 100% 0 to 1.88K | |
| 02-Jan-18 6:15 PM View: | Ono Richard Dana Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Option Exercise | 1,750 | -- | -- | 44% 4.0K to 5.75K | |
| 02-Jan-18 6:15 PM View: | Ono Richard Dana Director | Lipocine Inc. (LPCN) | 29-Dec-17 | Market Option Sale (Planned) | 875 | $3.47 | $3,033.36 | (15%) 5.75K to 4.88K | 51% |
